The invention relates to novel alicyclic N,N′-substituted diazabicyclo[3.3.1]nonane derivatives of general formula (I) which act as allosteric AMPA receptor modulators, and to drugs based thereon which can be used for treating Alzheimers, Parkinsons and other neurodegenerative diseases.